Exposure and virologic outcomes of dolutegravir combined with ritonavir boosted darunavir in treatment-naïve individuals enrolled in the Netherlands Cohort Study on Acute HIV infection (NOVA).

Saved in:
Bibliographic Details
Title: Exposure and virologic outcomes of dolutegravir combined with ritonavir boosted darunavir in treatment-naïve individuals enrolled in the Netherlands Cohort Study on Acute HIV infection (NOVA).
Authors: Prins, H.A.B.1 (AUTHOR), Zino, L.1,2 (AUTHOR) Leena.zino@radboudumc.nl, Svensson, E.M.2,3 (AUTHOR), Verbon, A.1 (AUTHOR), de Bree, G.J.4 (AUTHOR), Prins, J.M.4 (AUTHOR), Reiss, P.4,5 (AUTHOR), Burger, D.M.2 (AUTHOR), Rokx, C.1 (AUTHOR), Colbers, A.1,2 (AUTHOR)
Source: International Journal of Antimicrobial Agents. Jan2023, Vol. 61 Issue 1, pN.PAG-N.PAG. 1p.
Database: Environment Complete
Description
ISSN:09248579
DOI:10.1016/j.ijantimicag.2022.106697